You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
政府專家下午討論是否放寬兒童接種疫苗間距
阿思達克 10-13 09:21
政府認可復必泰疫苗的兒童及幼兒配方在香港緊急使用,政府專家顧問、疫苗可預防疾病科學委員會主席劉宇隆表示,今日(13日)下午會開會,討論會否放寬兒童的接種間距,例如是否可以縮短至不短於四星期後接種另一劑。他強調會考慮安全及近日確診數字有回升等因素。 劉宇隆在一個電台節目上稱,5至11歲的兒童,如果已接種第一針稀釋後的成人版復必泰疫苗,第二針可以選擇接種兒童配方復必泰。但如果幼童已接種過科興疫苗,不建議溝針接種。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account